Pimavanserin is a medication for hallucinations and delusions associated with Parkinson's disease. The drug is unusual in that it targets serotonin receptors rather than dopamine receptors. However, there are new concerns over the safety of pimavanserin following reports of mortality among patients. | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / Science Source / Greg Williams |
Taille de l’image : | 5700 px × 4800 px |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : | - |